When COVID‑19 swept the globe, clinical laboratories found themselves on the pandemic’s front lines – facing unprecedented test volumes, shattered supply chains, and fragmented data systems. In many regions, delays in test reporting and gaps in data sharing hampered public health responses. Yet labs that had invested in cross-compatible Laboratory Information Systems (LIS) discovered a powerful ally.
That ally was integrated platforms that delivered speed, accuracy, and traceability when they mattered most.
Early in the pandemic, a U.S. hospital system leveraged its LIS to automatically route SARS‑CoV‑2 test results to both clinicians and public health authorities within an hour of validation, thus shrinking the turnaround time by over 50% and enabling rapid isolation of positive cases.
As we brace for future threats, those lessons point toward a single conclusion: powerful disease surveillance starts with the right LIS.
Let’s understand how:
Speed, Accuracy, and Traceability in LIS During Epidemics
During an outbreak, every minute counts, and every sample must be tracked end‑to‑end. Modern LIS platforms, such as LabOS, automate tag‑and‑track workflows: barcoded specimens are logged at collection, scanned at each processing step, and time‑stamped in the system. This eliminates manual logbooks and ensures that no sample “falls through the cracks.”
In Sweden, the nationwide SmiNet surveillance system – linked directly to laboratory LIS feeds – received nearly 90,000 notifications of notifiable diseases in its first year, merging lab data with clinical case records using personal identifiers. Stakeholders praised its ability to generate real‑time outbreak alerts and detailed audit trails that supported policy decisions during COVID‑19.
With traceability locked in, labs can instantly trace a positive result back to the collection site, operator, and instrument – all critical when retracing contacts or validating batch runs.
Disease Surveillance Reporting & Cross‑Lab Collaboration
Outbreak control demands collaboration across hospitals, public health agencies, and reference labs. Centralized reporting to a single system, such as the U.S. National Notifiable Diseases Surveillance System (NNDSS), relies on labs pushing case data automatically from their LIS. That real‑time feed helps epidemiologists spot trends, deploy resources, and monitor intervention effectiveness.
The NNDSS collects data from all state, local, and territorial health departments. That way, they standardize formats and case definitions to ensure comparability nationwide. By integrating LIS outputs directly into NNDSS, labs eliminated batch uploads and manual data entry, thus reducing reporting errors by up to 30% and accelerating outbreak alerts by days rather than weeks.
According to Global Health, a collaborative project in Nigeria modernized paper-based typhoid surveillance. They did that by deploying mobile LIS terminals in regional labs. Results synced to a central dashboard, giving public health officials a live map of cases. In its first year, the system cut data aggregation time from two weeks to two days, enabling targeted vaccination drives and water and sanitation interventions in high‑risk communities.
Disease Surveillance – Connecting the LIS Dots
These examples all underscore a vital truth: the role of the laboratory in public health isn’t just about diagnostics – it’s about data, speed, and connection. When a crisis hits, labs can’t afford to rely on outdated, manual systems. A modern, cross-compatible LIS transforms a lab from a reactive testing site into a proactive force for public safety.
As we prepare for the next pandemic, or even localized outbreaks – and they will occur – the investment in upgrading your lab operations to a smart, connected laboratory infrastructure isn’t just strategic. It’s essential.
➡️ BOOST YOUR LAB
